These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11238688)

  • 1. Validating and improving models for projecting the absolute risk of breast cancer.
    Gail MH; Costantino JP
    J Natl Cancer Inst; 2001 Mar; 93(5):334-5. PubMed ID: 11238688
    [No Abstract]   [Full Text] [Related]  

  • 2. Stat bite: Incidence of in situ and invasive breast cancer by age, 1975-2001.
    J Natl Cancer Inst; 2004 Oct; 96(20):1496. PubMed ID: 15494597
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast.
    Bohlke K; Cramer DW; Trichopoulos D; Mantzoros CS
    Epidemiology; 1998 Sep; 9(5):570-3. PubMed ID: 9730040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ductal carcinoma in situ of the breast in younger women: a subgroup of patients at high risk.
    Tunon-de-Lara C; Lemanski C; Cohen-Solal-Le-Nir C; de Lafontan B; Charra-Brunaud C; Gonzague-Casabianca L; Mignotte H; Fondrinier E; Giard S; Quetin P; Auvray H; Cutuli B
    Eur J Surg Oncol; 2010 Dec; 36(12):1165-71. PubMed ID: 20889280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Projecting individualized absolute invasive breast cancer risk in African American women.
    Levine BR
    J Natl Cancer Inst; 2008 May; 100(9):683-4; author reply 684. PubMed ID: 18445823
    [No Abstract]   [Full Text] [Related]  

  • 6. Incidence of and treatment for ductal carcinoma in situ of the breast.
    Ernster VL; Barclay J; Kerlikowske K; Grady D; Henderson C
    JAMA; 1996 Mar; 275(12):913-8. PubMed ID: 8598618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50.
    Haile RW; Thomas DC; McGuire V; Felberg A; John EM; Milne RL; Hopper JL; Jenkins MA; Levine AJ; Daly MM; Buys SS; Senie RT; Andrulis IL; Knight JA; Godwin AK; Southey M; McCredie MR; Giles GG; Andrews L; Tucker K; Miron A; Apicella C; Tesoriero A; Bane A; Pike MC; ; ; Whittemore AS
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1863-70. PubMed ID: 17021353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma.
    Ernster VL; Barclay J
    J Natl Cancer Inst Monogr; 1997; (22):151-6. PubMed ID: 9709292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recreational physical activity, anthropometric factors, and risk of ductal carcinoma in situ of the breast in a cohort of postmenopausal women.
    Kabat GC; Kim M; Wactawski-Wende J; Lane D; Adams-Campbell LL; Gaudet M; Stefanick ML; Vitolins M; Chlebowski RT; Wassertheil-Smoller S; Rohan TE
    Cancer Causes Control; 2010 Dec; 21(12):2173-81. PubMed ID: 20814736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammographic density and estimation of breast cancer risk in intermediate risk population.
    Tesic V; Kolaric B; Znaor A; Kuna SK; Brkljacic B
    Breast J; 2013; 19(1):71-8. PubMed ID: 23173778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lobular carcinoma in situ of the breast].
    Llanos Muñoz M; Alonso Muñoz MC; Ojeda González B
    Med Clin (Barc); 1994 Oct; 103(14):553-6. PubMed ID: 7799670
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessing breast cancer risk: evolution of the Gail Model.
    Bondy ML; Newman LA
    J Natl Cancer Inst; 2006 Sep; 98(17):1172-3. PubMed ID: 16954464
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictors of breast recurrence after conservative surgery and radiation therapy for invasive breast cancer.
    Connolly JL; Boyages J; Nixon AJ; Peiró G; Gage I; Silver B; Recht A; Harris JR; Schnitt SJ
    Mod Pathol; 1998 Feb; 11(2):134-9. PubMed ID: 9504684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An epidemiologic study of differences between mammary ductal and lobular carcinoma in situ: analysis of 11,436 cases from the California Cancer Registry.
    Saltzstein SL
    Anat Pathol; 1996; 1():193-203. PubMed ID: 9390929
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection and treatment of ductal carcinoma in situ of the breast.
    Jatoi I
    JAMA; 1996 Sep; 276(11):870-1. PubMed ID: 8782629
    [No Abstract]   [Full Text] [Related]  

  • 17. Current management of ductal carcinoma in situ.
    Barth A; Brenner RJ; Giuliano AE
    West J Med; 1995 Oct; 163(4):360-6. PubMed ID: 7483593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the relative incidence of impalpable invasive breast carcinoma and ductal carcinoma in situ in cancers detected in patients older and younger than 50 years of age.
    Evans WP; Starr AL; Bennos ES
    Radiology; 1997 Aug; 204(2):489-91. PubMed ID: 9240541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer risk factor associations differ for pure versus invasive carcinoma with an in situ component in case-control and case-case analyses.
    Ruszczyk M; Zirpoli G; Kumar S; Bandera EV; Bovbjerg DH; Jandorf L; Khoury T; Hwang H; Ciupak G; Pawlish K; Schedin P; Masso-Welch P; Ambrosone CB; Hong CC
    Cancer Causes Control; 2016 Feb; 27(2):183-98. PubMed ID: 26621543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond the Gail model: lobular involution may help refine breast cancer risk assessment.
    Rowan K
    J Natl Cancer Inst; 2009 Feb; 101(3):134-5. PubMed ID: 19176450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.